Robert Shrewsbury

1. Foster T.S., Shrewsbury R.P., Coonrod J.D.: Bioavailability and Pain Study of Cefamandole Nafate. Journal of Clinical Pharmacology 20:526-533 (1980).

2. Shrewsbury R.P., Foster T.S., Dittert L.W., Quigley J.W., Leavell U.M.: Percutaneous Absorption of Hydroxyurea Through Psoriatic Lesions. Current Therapeutic Research 28:1002-1011 (1980).

3. Hieb B.R., Shrewsbury R.P.: Consecutive Intravenous Infusions: Simulations of Two Compartment Pharmacokinetic Drugs. Computer Programs in Biomedicine 12:96-104 (1980).

4. Wurster D.E., Shrewsbury R.P.: Simulation Package for Multiple Intravenous Infusions of Two Compartment Pharmacokinetic Drugs. International Journal of Bio-Medical Computing 12:455-470 (1981).

5. Shrewsbury R.P., Metcalf T.B., Weiss D.L., Dittert L.W.: Influence of Disodium Etidronate on the Absorption of Salicylic Acid in the Rat. Journal of Pharmacy and Pharmacology 34:823-825 (1982).

6. Shinn A.F., Shrewsbury R.P.: The Drug Interaction Dilemma. Computertalk Directory of Pharmacy Systems-1983. 34:39 (1983).

7. Shinn A.F., Shrewsbury R.P., Anderson K.A.: Development of a Computerized Drug Information Database (Medicom®) for Use in a Patient Specific Environment. Drug Information Journal 17:205-210 (1983).

8. Swarbrick J., Shrewsbury R.P.: The Prolonged Retention of Sodium Cromoglycate in the Rabbit Eye. Journal of Pharmacy and Pharmacology 36:121-122 (1984).

9. Shrewsbury R.P., Wurster D.E., Dittert L.W.: Dose Dependent Effect of Calcium and Magnesium Etidronate on Salicylic Acid Absorption in the Rat. Journal of Pharmacy and Pharmacology 37:440-442 (1985).

10. Gural R.P., Chungi V.S., Shrewsbury R.P., Dittert L.W.: Dose Dependent Absorption of Disodium Etidronate. Journal of Pharmacy and Pharmacology 37:443-445 (1985).

11. Shrewsbury R.P., Swarbrick J., Newton K.S., Riggs L.C.: Influence of Ophthalmic Formulations on Sodium Cromoglycate Disposition in the Albino Rabbit Eye. Journal of Pharmacy and Pharmacology 37:614-617 (1985).

12. Shrewsbury R.P.: Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Ampicillin Kinetics. Journal of Pharmacy and Pharmacology 38:647-652 (1986).

13. Shrewsbury R.P., White S.G., Pollack G.M., Wargin W.A.: Antipyrine Kinetics Following Partial Blood Exchange with Fluosol-DA in the Rat. Journal of Pharmacy and Pharmacology 38:883-887 (1986).

14. Merritt J.C., Shrewsbury R.P., Locklear F., Demby K.B., Wittle G.L.: Effects of D9-Tetrahydrocannabinol and Vehicle Constituents on Intraocular Pressure in Normotensive Dogs. Research Communications in Substances of Abuse 7:29-35 (1986).

15. Shrewsbury R.P.: Effect of Fluosol-DA Hemodilution on the Kinetics of Hepatically Eliminated Drugs. Research Communications in Chemical Pathology and Pharmacology 55:375-396 (1987).

16. Shrewsbury R.P., Lewis L.M., Oliver S.R.: Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Low-Dose Phenytoin and (±)-5-(4-hydroxyphenyl)-5-phenylhydantoin Kinetics. Journal of Pharmacy and Pharmacology 39:349-356 (1987).

17. Shrewsbury R.P., Lewis L.M., Oliver S.R., Womble C.L.: Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Indocyanine Green and (+)-Propranolol Kinetics. Journal of Pharmacy and Pharmacology 39:592-598 (1987).

18. Hall I.H., Reynolds D.J., Wyrick S.D., Maguire J.H., Shrewsbury R.P.: The Disposition of the Hypolipidemic Agent, 14C-o-(N-phthalimido)acetophenone, in Sprague Dawley Rats. Drug Disposition and Metabolism 16:196-200 (1988).

19. Shrewsbury R.P., Oliver S.R., Lewis L.M., Anderson, W.T.: Effect of Different Hemodilution Percentages with Fluosol-DA or Normal Saline on Antipyrine Kinetics in the Rat. Biomaterials, Artificial Cells, and Artificial Organs 16:695-697 (1988). Also in: Chang T.M.S., Geyer R.P. (editors) Blood Substitutes, Marcel Dekker, New York, 1989, pp. 695-697.

20. Shrewsbury R.P., Oliver S.R., Anderson W.T., Lewis L.M., White L.G.: The Effect of Varying Percentages of Hemodilution with Fluosol-DA and Normal Saline of Antipyrine Metabolism in the Rat. Journal of Pharmacy and Pharmacology 40:392-398 (1988).

21. Shrewsbury R.P., White L.G.: Some Insights into the Variations in Antipyrine Pharmacokinetics in the Rat. Research Communications in Chemical Pathology and Pharmacology 62:137-140 (1988).

22. Shrewsbury R.P., Oliver S.R., White L.G.: The Effect of Moderately Severe Hemodilution with Fluosol-DA on Cytochrome P-450 Mediated Antipyrine Metabolism. Biomaterials, Artificial Cells, and Artificial Organs 17:393-402 (1989).

23. Shrewsbury R.P., Oliver S.R., Lewis L.M., Anderson W.T., White L.G.: The Effect of Varying Extents of Fluosol-DA or Normal Saline Hemodilution on the Dose Dependent Kinetics of Phenytoin in the Rat. Journal of Pharmacy and Pharmacology 41:582-584 (1989).

24. Shrewsbury R.P., White L.G.: The Effect of Moderate Fluosol-DA Hemodilution on Gender Specific Metabolism of Antipyrine. Research Communications in Chemical Pathology and Pharmacology 64:455-462 (1989).

25. Hall I.H., Oswald C.B., Wyrick S.D., Maguire J.H., Shrewsbury R.P.: Disposition of the Hypolipidemic Agent, 14C-2,3-Dihydrophthalazine-1,4-dione, in Sprague Dawley Rats. Journal of Pharmacy and Pharmacology 41:394-397 (1989).

26. Shrewsbury R.P., Oliver S.R., Anderson W.T., Lewis L.M., White L.G.: The Effect of Varying Percentages of Fluosol-DA Hemodilution on Antipyrine Metabolism in the Rat. in: Hanker J.S., Giammara B.L. (editors) Biomedical Materials and Devices, Materials Research Society Symposium Proceedings, Vol. 110, Materials Research Society, Pittsburgh, PA., 1989, pp. 147-151.

27. Oswald C.B., Wyrick S.D., Chaney S.G., Shrewsbury R.P., Hall I.H.: Disposition of Cisplatin Derivatives 3H-Cis-1,2-Diaminocyclohexanedichloro-platinum (II) and 3H-Cis-1,2-Diaminocyclohexanemalonato-platinum (II) in BDF₁ Mice. Research Communications in Chemical Pathology and Pharmacology 64:41-58 (1989).

28. Shrewsbury R.P., White L.G.: Failure to Detect Heparin in Plasma Containing Fluosol-DA Using an Analytical Kit. Clinica Chimica Acta 179:347-348 (1989).

29. Shrewsbury R.P., White L.G.: Effect of the Method of Fluosol-DA Administration on Antipyrine Disposition in the Rat. Journal of Pharmacy and Pharmacology 42:813-816 (1990).

30. Shrewsbury R.P., Hong D.D.: The Effect of Fluosol-DA and Hespan Hemodilution on S-Warfarin Elimination in the Rat. Journal of Pharmacy and Pharmacology 42:665-666 (1990).

31. Shrewsbury R.P., White L.G.: The In Situ Absorption of Antipyrine as a Measure of Intestinal Blood Flow in Fluosol-DA Hemodiluted Rats. Journal of Pharmacy and Pharmacology 42:511-512 (1990).

32. Collier A.M., Goldstein G.M., Shrewsbury R.P., Zhang C.A., Williams R.W.: Urine Cotinine Elimination Half-life in Young Children Exposed to Side-stream Cigarette Smoke. Proceedings of the Fifth International Conference on Indoor Air Quality and Climate, Vol. 2, 1990, pp. 195-200.

33. Shrewsbury R.P., White L.G.: Evaluation of Cytochrome P-450 Mediated Metabolism of Antipyrine in the Rat at Different Extents of Fluosol-DA Hemodilution. Research Communications in Chemical Pathology and Pharmacology 67:411-414 (1990).

34. Shrewsbury R.P., White L.G.: The Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Acetaminophen Metabolism in the Rat. Experientia 46:213-217 (1990).

35. Grippo A.A., Wyrick S.D., Lee K.H., Shrewsbury R.P., Hall I.H.: Disposition of an Antineoplastic Sesquiterpene Lactone, 3H-Plenolin, in BDF1 Mice. Planta Medica 57:309-314 (1991).

36. Shrewsbury R.P.: Plasma Volumes, Blood Volumes, and Plasma Protein Concentrations After Moderate Hemodilution with Fluosol-DA or Normal Saline in the Rat. Journal of Pharmacy and Pharmacology 43:371-374 (1991).

37. Hall I.H., Wong O.T., Wyrick S.D., Simlot R., Shrewsbury R.P.: Disposition of the Hypolipidemic Agent, 6-Amino-2-mercapto-5-methylpyrimidine-4-carboxylic acid, in Sprague Dawley Rats. Journal of Pharmacy and Pharmacology 43:360-363 (1991).

38. Hall I.H., Wong O.T., Sood A., Sood C.K., Spielvogel B.F., Shrewsbury R.P., Morse K.W.: Hypolipidemic Activity in Rodents of Boron Analogs of Phosphonoacetates and Cyanoborane Adducts of Dialkyl Aminomethylphosphonates. Pharmacological Research 25:259-270 (1992).

39. Shrewsbury R.P.: Acute Effects of Moderate Fluosol-DA Hemodilution on Hepatic Microsomal and Nonmicrosomal Metabolism in Rats. Biomaterials, Artificial Cells, and Immobilization Biotechnology 20:1037-1043 (1992).

40. Shrewsbury R.P., Hong D.D., White L.G., Gordon T.R.: The Effect of Moderate Hemodilution with Fluosol-DA or Hespan on the Nonmicrosomal Acetylation of Sulfamethazine in the Rat. Journal of Pharmacy and Pharmacology 44:84-88 (1992).

41. Hadzija B.W., Shrewsbury R.P.: Participation of Graduate Students in the Undergraduate Instruction of Pharmaceutics. Journal of Pharmacy Teaching 4:11-19 (1993).

42. Collier A.M., Goldstein G.M., Shrewsbury R.P., Davis S.M., Koch G.G., Zhang C.A., Benowitz N.L., Lewtas J., Williams R.W.: Cotinine Elimination Following ETS Exposure in Young Children as a Function of Age, Sex, and Race. Proceedings of the Sixth International Conference on Indoor Air Quality and Climate 1:669-674 (1993).

43. Burnham B.S., Hall I.H., Shrewsbury R.P., Hall E.S., Sood A., Spielvogel B.F.: Disposition and Distribution of the Cytidine Cyanoborane Adduct, [2-14C]-2’-Deoxycytidine-3N-cyanoborane in CF1 Mice. Drug Investigation 6:75-82 (1993).

44. Collier A.M., Goldstein G.M., Shrewsbury R.P., Davis S.M., Koch G.G., Zhang C.A., Benowitz N.L., Lewtas J., Williams R.W.: Cotinine Elimination and Its Use as a Biomarker in Young Children Involuntarily Exposed to Environmental Tobacco Smoke. Indoor Environment 3:353-359 (1994).

45. Shrewsbury R.P., Oliver S.R., White L.G.: The Effect of Moderate Hemodilution with Fluosol on Cytochrome P4502D6 Activity in the Rat. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 22:1237-1242 (1994).

46. Shrewsbury R.P., Wyrick S.D., Elkins A.L., Izydore R.A., Chen S.Y., Miller III M.C., Burnham B.S., Hall I.H.: Disposition of the Pharmacologically Active Compound [1-14C-Acetyl]-1-Acetyl-4-Phenyl-1,2,4-Triazolidine-3,5-Dione in CF1 Mice. Drug Investigation 7:275-281 (1994).

47. Murphy M.E, Shrewsbury R.P., Sood A., Spielvogel B.F., Elkins A.L., Hall I.H.: The Relationship Between Cytokine Regulation and Anti-inflammatory Action of Amine-Carboxyborane in L929 Fibroblasts and IC-21 Macrophages. Metal-Based Drugs 2(5) 257-269 (1995).

48. Miller III M.C., Shrewsbury R.P., Elkins A.L., Sood A., Spielvogel B.F., Hall I.H.: The Disposition, Tissue Distribution, and Cellular Transport of N-[[(Trimethylamino)boryl]carbonyl]-L-Phenylalanine Methyl Ester in CF1 Mice. Journal of Pharmaceutical Sciences 84:933-936 (1995).

49. Hadzija B.W., Shrewsbury R.P.: Two Basic Pharmacy Courses with Strong Experimental (Laboratory) Component. Journal of Pharmacy Teaching 5:41-50 (1996).

50. Miller III M.C., Sood A., Spielvogel B.F., Shrewsbury R.P., Hall I.H.: The Pharmacological Activities of the Metabolites of N-[[(Trimethylamino)boryl]carbonyl]-L-Phenylalanine Methyl Ester. Metal Based Drugs 3:219-226 (1996).

51. Hadzija B.W., Shrewsbury R.P.: Determination of Hydrocodone in Tussionex Extended-Release Suspension by High-Performance Liquid Chromatography (HPLC). Journal of Forensic Sciences 41:878-880 (1996).

52. Murphy M.E., Elkins A.L., Shrewsbury R.P., Sood A., Spielvogel B.F., Hall I.H.: The Effects of Amine-Carboxyborane Related Derivatives on UMR-106 Bone Metabolism. Metal-Based Drugs 3:31-47 (1996).

53. Hall M.E., Shrewsbury R.P., Chen S.Y., Elkins A.L., Burnham B.S., Spielvogel B.F., Hall I.H.: The Disposition and Tissue Distribution of Trimethylamine-(14C)-Carboxyborane and Trimethylamine-(14C)-Carboxymethoxyborane in CF1 Mice. Pharmaceutical Sciences 3:473-478 (1997).

54. Hadzija B.W., Shrewsbury R.P.: Atropine Overdose with a Suppository Formulation Containing Atropine Sulfate. International Journal of Pharmaceutical Compounding 1:271-273 (1997).

55. Wright L.N., Thorp Jr. J.M., Kuller J.A., Shrewsbury R.P., Ananth C., Hartmann K.: Transdermal Nicotine Replacement in Pregnancy: Maternal Pharmacokinetics and Fetal Effects. American Journal of Obstetrics and Gynecology 176:1090-1094 (1997).

56. Shrewsbury R.P., Johnson L.W., Oliver S.R.: Influence of Moderate Hemodilution with Fluosol or Normal Saline on Carbaryl Disposition in Sprague-Dawley Rats. Journal of Pharmacy and Pharmacology 49:236-240 (1997).

57. Shrewsbury R.P., Deloatch K.H.: Accuracy in Prescriptions Compounded by Pharmacy Students. International Journal of Pharmaceutical Compounding 2:139-142 (1998).

58. Hadzija B.W., Shrewsbury R.P.: Stability of Four Commercial Products Delivered by Mail Order. International Journal of Pharmaceutical Compounding 3:59-63 (1999).

59. Shrewsbury R.P.: A Hybrid CD-Internet Delivery System for Pharmaceutical Care Laboratory Instruction. North American Web 2000 International Meeting, http://naweb.unb.ca/2k/posters/Shrewsbury1.html (2000).

60. Shrewsbury R.P.: University of North Carolina at Chapel Hill School of Pharmacy Pharmaceutical Care Laboratories: Compounding Laboratory Curriculum and Renovation. International Journal of Pharmaceutical Compounding 10:353-358 (2006).

1. Shinn A.F., Shrewsbury R.P.: Evaluations of Drug Interactions, 3rd edition. C.V. Mosby Co., St. Louis, Missouri, 1985. A title of the American Pharmaceutical Association.

2. Shrewsbury R.P. (contributing author): The Pharmacy Technician, Morton Publishing Co., Englewood, Colorado, 1999. A title in the American Pharmaceutical Association’s Basic Pharmacy and Pharmacology Series. Also has an associated text, Workbook & Certification Review, Morton Publishing Co., Englewood, Colorado, 1999.

3. Shrewsbury R.P. (contributing author): Basic Pharmacology, Morton Publishing Co., Englewood, Colorado, 2000. A title in the American Pharmaceutical Association’s Basic Pharmacy and Pharmacology Series.

4. Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding, Morton Publishing Co., Englewood, Colorado, 2001.

5. Shrewsbury R.P. (contributing author): The Pharmacy Technician, 2nd Edition, Morton Publishing Co., Englewood, Colorado, 2004. A title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series. Also has an associated text, Workbook & Certification Review, 2nd Edition, Englewood, Colorado, 2004.

6. Shrewsbury R.P. (contributing author): The Pharmacy Technician, 3rd Edition, Morton Publishing Co., Englewood, Colorado, 2007. A title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series. Also has an associated text, Workbook & Certification Review, 3rd Edition, Englewood, Colorado, 2007.

7. Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding, 2nd Edition, Morton Publishing Co., Englewood, Colorado, 2008.

1. Shrewsbury R.P.: Pharmaceutical Laboratory Learning CD, University of North Carolina School of Pharmacy (1999).

2. Pittman A.W., Shrewsbury R.P., Bastow K.F., Campbell W.H., Christensen D.B., Dell K.A., Deloatch K.H., Joyner P.U., Raasch R.H., Early M.E.: Self-Study Report for the Doctor of Pharmacy Curriculum, University of North Carolina School of Pharmacy (1999).

1. Pharmaceutical Laboratory Web Site. A web resource for Doctor of Pharmacy level courses in Compounding and Pharmaceutics, 1996-present. The site is listed as a Basic Resource for Pharmaceutical Education by the American Association of Colleges of Pharmacy. It is also listed as a Compounding Resource by the American Society of Health-System Pharmacists.

2. Pharmacy Licensure Review (PLR). A study module for Doctor of Pharmacy students to prepare for the national pharmacy licensure examination (NAPLEX©). Available through the Professional Compounding Centers of America, Inc., Houston, Texas.

3. Advanced Pharmaceutical Compounding. A Doctor of Pharmacy level course in advanced comounding science and techniques. Available through the Professional Compounding Centers of America, Inc., Houston, Texas.

1. Shrewsbury R.P., Wurster D.E., Dittert L.W.: Dose Dependent Effect of Disodium Etidronate on Salicylic Acid Absorption in the Rat. Abstracts of the 33rd National Meeting of the Academy of Pharmaceutical Sciences, San Diego, California, 12:170 (1982).

2. Shrewsbury R.P., Swarbrick J., Newton K.S., Riggs L.C.: The Retention of Topically Applied Sodium Cromoglycate in the Albino Rabbit Eye. Abstracts of the 36th National Meeting of the Academy of Pharmaceutical Sciences, Montreal, Canada, 14:69 (1984).

3. White S.G., Wargin W.A., Shrewsbury R.P.: Antipyrine Kinetics Following Perfluorochemical (PFC) Emulsion-Blood Exchange. Abstracts of the 37th National Meeting of the Academy of Pharmaceutical Sciences, Philadelphia, Pennsylvania, 14:232 (1984).

4. Reynolds D.J., Wyrick S.D., Shrewsbury R.P., Hall I.H.: The Metabolic Disposition of the Hypolipidemic Agent o-(N-Phthalimido)acetophenone in Rodents. Pharmacologist 27:211 (1985).

5. Grippo A.A., Wyrick S.D., Shrewsbury R.P., Chaney S.G., Holbrook D.J., Lee K.H., Hall I.H.: The Disposition of (3H)-11,13-Dihydrohelenalin, a Derivative of the Sesquiterpene Lactone Helenalin. Pharmacologist 27:109 (1985).

6. Shrewsbury R.P., Dorr M.B., Pollack G.M.: Effects of Anesthesia and Blood Replacement on Antipyrine Kinetics in Rats. Abstracts of the 38th National Meeting of the Academy of Pharmaceutical Sciences, San Antonio, Texas, 15:111 (1985).

7. Shrewsbury R.P., Lewis L.M., Oliver S.R.: Phenytoin Kinetics Following Partial Fluosol-DA or Normal Saline Blood Exchange. Pharmaceutical Research 3(No. 5 Suppl.):161S (1986).

8. Shrewsbury R.P.: Ampicillin Kinetics Following Partial Fluosol-DA or Normal Saline Blood Exchange. Abstracts of the 133rd Annual Meeting of the American Pharmaceutical Association, San Francisco, California, 16:127 (1986).

9. Shrewsbury R.P., Oliver S.R., Lewis L.M.: Dose Dependent Effect of Fluosol-DA and Normal Saline Hemodilution on Antipyrine Kinetics in the Rat. Biomaterials, Artificial Cells, and Artificial Organs 15:662 (1987).

10. Shrewsbury R.P., Lewis L.M., Oliver S.R., Womble C.L.: Indocyanine Green and d-Propranolol Kinetics Following Moderate Fluosol-DA or Normal Saline Hemodilution. Pharmaceutical Research 4(No. 2 Suppl.):S119 (1987).

11. Shrewsbury R.P., Oliver S.R., Lewis L.M., Anderson W.T., White L.G.: The Effect of Varying Percentages of Hemodilution With Fluosol-DA and Normal Saline on Antipyrine Metabolism in the Rat. Journal of Pharmaceutical Sciences 76:S96 (1987). Also in the Abstracts of the 1987 Fall Meeting of the Materials Research Society, Boston, Massachusetts, p. 347 (1987).

12. Shrewsbury R., Oliver S., White L.: Effect of Varying Percentages of Hemodilution with Fluosol-DA or Normal Saline on Indocyanine Green and d-Propranolol Disposition in the Rat. Pharmaceutical Research 5(No. 10 Suppl.):S194 (1988).

13. Shrewsbury R.P., White L.G.: The Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Acetaminophen Metabolism in the Rat. Pharmaceutical Research 6(No. 9 Suppl.):S205 (1989).

14. Shrewsbury R., White L.: Influence of the Method of Fluosol-DA Administration on Antipyrine Metabolism in the Rat. Pharmaceutical Research 7(No. 9 Suppl.):S262 (1990).

15. Burnham B.S., Wyrick S.D., Shrewsbury R.P., Shaw B.R., Sood A., Spielvogel B.F., Hall I.H.: Radiolabelled Synthesis of [2-14C]-2'-Deoxycytidine-3N-cyanoborane, Tissue Disposition in Mice, and Antineoplastic Mode of Action in T-Molt Leukemic Cells. Abstracts of the Boron USA Workshop (BUSA II), Research Triangle Park, North Carolina, p. 63 (1990).

16. Shrewsbury R., Hong D., White L., Gordon T.: The Effect of Moderate Fluosol-DA or Hespan Hemodilution on the Nonmicrosomal Acetylation of Sulfamethazine in the Rat. Pharmaceutical Research 8(No. 10 Suppl.):234 (1991).

17. Shrewsbury R.P., White L.G.: Acute Effects of Moderate Fluosol-DA Hemodilution on Hepatic Microsomal and Nonmicrosomal Metabolism in Rats. Biomaterials, Artificial Cells, and Immobilization Biotechnology 19:485 (1991).

18. Collier A.M., Goldstein G.M., Shrewsbury R.P., Zhang C.A., Benowitz N.L., Williams R., Lewtas J.: Cotinine Elimination in Young Children as a Function of Age, Sex, and Race Following ETS Exposure. American Reviews of Respiratory Disease 145 (No. 4 Suppl., part 2):A532 (1992).

19. Shrewsbury R.P., Oliver S.R., White L.G.: The Effect of Moderate Fluosol-DA Hemodilution on Desipramine Pharmacokinetics in the Rat. Abstracts of the 5th International Symposium on Blood Substitutes, San Diego, California, p. F38 (1993).

20. Hall I.H., Rajendran K.G., Chen S.Y., Burnham B.S., Murphy M.E., Shrewsbury R.P., Sood A., Spielvogel B.F., Morse K.W., Norwood III V.M.: Anti-inflammatory Activity and Cytokine Modulation of Trimethylamine Carboxyboranes and Related Derivatives. Abstracts of the 8th International Meeting in Boron Chemistry, Knoxville, Tennessee (1993).

21. Elkins A.L., Cho M., Shrewsbury R.P., Sood A., Spielvogel B.F., Hall I.H., Miller III M.C.: Cellular Uptake and Tissue Disposition of Trimethylamine Carboxyborane-phenylalanine Methyl Ester in CF1 Mice and L-1210 Lymphoid Cells. Abstracts of the 8th International Meeting in Boron Chemistry, Knoxville, Tennessee (1993).

22. Shrewsbury R.P., Izydore R.A., Hall I.H.: 1-Acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione. Drug Data Reports 17:393 (1993).

23. Sood A., Spielvogel B.F., Hall I.H., Cho M.J., Shrewsbury R.P., Powell W.J., Karthikeyan S., Miller III M.C., Elkins A.L.: Amine-carboxyboranes (Analogs of a-Amino Acids): Building Blocks for New Peptide Libraries. Abstracts of the Molecular Diversity Symposium, North Carolina Biotechnology Center, Research Triangle Park, North Carolina, pp. 14-15 (1994).

24. Ely J.G., Hall I.H., Elkins A.L., Shrewsbury R.P.: Transepithelial Transport of Boronated Dipeptides Across a Cell Model: HCT-8. Abstracts of the 142nd Annual Meeting of the American Pharmaceutical Association, Orlando, Florida (1994).

25. Hadzija B.W., Shrewsbury R.P.: Two Basic Pharmacy Courses with Strong Experimental (Laboratory) Components. Abstracts of the 97th Annual Meeting of the American Association of Colleges of Pharmacy, Reno, Nevada, p. 148 (1996).

26. Pulliam C.C., Joyner P.U., Shrewsbury R., Carson S.W., Pittman A.W., Vaisman I.: World Wide Web Applications to Benefit Distance Learning in an External Doctor of Pharmacy Program. Abstracts of the 98th Annual Meeting of the American Association of Colleges of Pharmacy, Indianapolis, Indiana, p. 37 (1997).

27. Pittman A.W., Shrewsbury R.P., Bastow K.F., Campbell W.H., Christensen D.B., Dell K.A., Deloatch K.H., Joyner P.U., Raasch R.H.: A CD-ROM/Web-Based ACPE Self Study. Abstracts of the 101st Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, California, # 43 (2000).

28. Shrewsbury R.P., Deloatch K.H.: Lecture Outcome - Cape Outcome Review (LOCOR) Project. Abstracts of the 101st Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, California, # 46 (2000).

29. Shrewsbury R.P.: A Hybrid CD-Internet Delivery System for Pharmaceutical Care Laboratory Instruction. Abstracts of the 101st Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, California, # 56 (2000).

30. Stegall-Zanation J., White-Harris C., Shrewsbury R., Reuning S.: A DVD Demonstration Tool to Enhance Knowledge of Curricular Courses. Abstracts of the 2005 Annual Meeting of the American Association of College of Pharmacy, Cincinnati, Ohio, # xx (2005).